REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial.

Autor: Martin-Broto, Javier1,2,3 (AUTHOR) jmartin@atbsarc.org, Valverde, Claudia4 (AUTHOR), Hindi, Nadia1,2,3 (AUTHOR), Vincenzi, Bruno5 (AUTHOR), Martinez-Trufero, Javier6 (AUTHOR), Grignani, Giovanni7 (AUTHOR), Italiano, Antoine8 (AUTHOR), Lavernia, Javier9 (AUTHOR), Vallejo, Ana10 (AUTHOR), Tos, Paolo Dei11 (AUTHOR), Le Loarer, Francois12 (AUTHOR), Gonzalez-Campora, Ricardo13 (AUTHOR), Ramos, Rafael14 (AUTHOR), Hernández-Jover, Diana15 (AUTHOR), Gutierrez, Antonio16 (AUTHOR), Serrano, Cesar4 (AUTHOR), Monteagudo, Maria17 (AUTHOR), Letón, Rocio17 (AUTHOR), Robledo, Mercedes17,18 (AUTHOR), Moura, David S.1 (AUTHOR)
Zdroj: Molecular Cancer. 8/9/2023, Vol. 22 Issue 1, p1-8. 8p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje